Dario and GreenKey Join Forces to Target $150 Billion Sleep Apnea Market, Addressing 29 Million Americans with Unmet Needs Through Integrated Chronic Care Solution

DarioHealth, a leader in the global digital health market, announced a strategic commercial agreement with GreenKey Health, an innovator in value-based sleep health solutions, to bring the comprehensive care program to payers nationwide. The collaboration leverages the strengths of both companies to deliver a tiered, data-driven solution for improving member health outcomes, reducing healthcare costs, and enhancing productivity through the integration of behavioral health, sleep, and cardiometabolic care. The collaboration targets the $150 billion sleep apnea market affecting over 29 million Americans, with up to 80% of moderate to severe cases currently undiagnosed.

Health Technology Insights: Cherokee Health Systems Rebrands as River Valley Health

This collaboration unites Dario’s clinically validated cardiometabolic and behavioral artificial intelligence (‘AI’)-powered health solutions with GreenKey’s ‘sleep-first’ approach to obstructive sleep apnea (‘OSA’) management. Together, the organizations aim to drive awareness, and secure payer contracts, through a robust multi-channel marketing plan designed to engage Commercial, ASO (‘Administrative Services Only’), Medicaid, and Medicare Advantage plans, as well as self-funded employers, consultants, brokers, and value-based care providers.

The immediate joint launch of the collaboration will focus on engaging large payers as strategic channel collaborators while building a national network of aligned service providers. The strategic initiatives will utilize a mix of targeted outreach, thought leadership, and high-impact content to connect with decision-makers and advance adoption of this innovative, value-based care model.

OSA affects over 29 million Americans, with up to 80% of moderate to severe cases undiagnosed, driving more than $150 billion in annual U.S. costs due to associated cardiometabolic and behavioral comorbidities like diabetes, obesity, hypertension, and depression. As payers increasingly shift toward value-based care, there is a growing need for integrated solutions that address these interconnected conditions. Combining GreenKey’s sleep-first approach with Dario’s proven cardiometabolic and behavioral health programs delivers a holistic, data-driven solution that improves clinical outcomes, reduces healthcare costs, and meets the market demand for comprehensive, high-return on investment (‘ROI’) chronic condition management.

Health Technology Insights: Elsevier Launches Embase AI for Biomedical Research Insights

“We believe that this agreement marks a pivotal step forward in reshaping how chronic conditions like sleep apnea and cardiometabolic disorders are addressed in tandem,” said Steven Nelson, Chief Commercial Officer at Dario. “By combining our real-time engagement and data-driven platform with GreenKey’s powerful OSA cost-saving engine, we are offering payers a differentiated, value-based care solution that not only improves health outcomes but significantly reduces the total cost of care. This collaboration opens access to a multi-billion-dollar market and aligns perfectly with our mission to provide integrated, data-driven solutions for the most prevalent and costly chronic conditions facing healthcare today.”

This joint solution is a comprehensive, tiered program that delivers:

  • Improved Member Outcomes through enhanced sleep health, optimized GLP-1 utilization, and effective comorbidity management
  • Reduced Healthcare Costs with decreased Emergency Department and inpatient utilization
  • Increased Productivity from better sleep and overall health
  • Actionable Data Insights to continuously optimize program performance

Studies have shown that even weight loss of 10% can lead to a substantial reduction in apnea–hypopnea index (‘AHI’), indicating a decrease in the severity of sleep apnea. AHI is a simple measure of how often during sleep someone either completely stops breathing or breathes much more shallowly. “We are excited to collaborate with Dario, a proven leader in digital health engagement and outcomes,” said Michael Markus, Chief Executive Officer of GreenKey Health. “Our collaboration offers payers a unique opportunity to activate a clinically integrated funnel that identifies the right patients for the right programs—starting with sleep and extending through behavior and cardiometabolic health. This is how we redefine chronic care for the modern healthcare system.”

By aligning behavioral health and sleep-first strategies with precision cardiometabolic interventions, the Dario-GreenKey collaboration provides a superior offering that meets the growing demand for integrated, measurable chronic care solutions.

Health Technology Insights: First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – PR Newswire